Café

© 2026 Longbridge｜Terms of Service Privacy Policy

NEXGEL shares are trading higher after the company announced data from randomized, 30-patient, single-center Institutional Review Board clinical study.

NEXGEL shares are trading higher after the company announced data from randomized, 30-patient, single-center Institutional Review Board clinical study.

benzinga_article

May 19, 2026 at 01:14 PM

NEXGEL shares are trading higher after the company announced data from randomized, 30-patient, single-center Institutional Review Board clinical study.

Source: benzinga_article The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

Nexgel

USNXGL

+1.95%

NEXGEL INC C/WTS 27/12/2026 (TO PUR COM)

USNXGLW

iShares Biotechnology ETF

USIBB

LongbridgeAI